Blue Owl Capital Holdings LP 13D and 13G filings for Sagimet Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
Blue Owl Capital Holdings LP | 1,323,877 4.320% |
-350,000 (-20.91%) |
Filing |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
Blue Owl Capital Holdings LP | 1,673,877 5.460% |
1,673,877 (New Position) |
Filing |